> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pathology Peer Review Q&A Guidance
- URL: https://www.fdaweb.com/pathology-peer-review-q-a-guidance/
- Published: 2019-08-01T12:00:00.000Z
- Updated: 2026-09-15T01:41:30.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144665

FDA has issued a draft guidance, *Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers*, with information for sponsors and nonclinical laboratory staff about the management and conduct of pathology peer review performed during good laboratory practice-compliant toxicology studies. “When conducted, pathology peer review should be well-documented,” the [document](https://www.fda.gov/media/129533/download?ref=fdaweb.com) says. “However, documentation practices during pathology peer review have not been clearly defined and vary among nonclinical testing facilities. This question-and-answer document is intended to clarify FDA’s recommendations concerning the management, conduct, and documentation of pathology peer review.”